Xiaodong Wang

Director

Xiaodong Wang (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in BGNE. The largest single filing was $13.4M of ONC (38,287 sh across 8 lots, as filed), executed Sep 8. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$46.7M

shares × price, as filed

Last traded

Oct 27

Filed Oct 29

Median ADV $130.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $114.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

BGNE BGNE 0 buys · 8 sells 8 filings ONC

BeOne Medicines AG ONC · 0 buys · 6 sells 6 filings

Recent filings

BGNESALE BeiGene, Ltd. View filing → $10.9M
41,760 sh across 7 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $2.0M
7,823 sh across 6 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $9.4M
41,760 sh across 6 lots
Exec Feb 4 2025
Filed Feb 6 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $7.4M
41,760 sh across 5 lots
Exec Jan 7 2025
Filed Jan 8 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $7.7M
41,460 sh across 10 lots
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $8.9M
47,044 sh across 13 lots
Exec Nov 26 2024
Filed Nov 29 2024 · 5:30 PM ET